Mountain Crest Acquisition

$0.00 (0.00%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can watch MCAD and buy or sell other stocks, options, and ETFs commission-free!

About MCAD

Better Therapeutics, Inc. develops software-based prescription digital therapeutics for treating diabetes, heart disease, and other cardiometabolic conditions. It engages in developing a proprietary platform for the development of FDA-regulated, software-based solutions for type 2 diabetes, heart disease and other conditions.

CEO
Kevin J. Appelbaum
Employees
44
Headquarters
San Francisco, California
Founded
2015

MCAD Key Statistics

Market cap
246.18M
Price-Earnings ratio
—
Dividend yield
—
Average volume
2.11M
High today
—
Low today
—
Open price
—
Volume
0.00
52 Week high
$29.40
52 Week low
$0.912
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure